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PRECIS 36 
In a multicenter study, the TBI was developed using random forest method with leave-one-out 37 
cross-validation (RF/LOOCV) for combining parameters from Scheimpflug-based corneal 38 
tomography and biomechanical assessments for enhanced ectasia detection. 39 
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ABSTRACT 45 
Purpose: To present the Tomographic/Biomechanical Index (TBI), that combines 46 
Scheimpflug-based corneal tomography and biomechanics for enhancing ectasia 47 
detection. Methods: Patients from different continents were studied. One eye randomly 48 
selected from 480 patients with normal corneas and from 204 keratoconus patients 49 
comprised groups I and II respectively. Group III included 72 non-operated ectatic eyes 50 
from 94 patients with very asymmetric ectasia, whose fellow eyes (group IV) presented 51 
with normal topography. Pentacam HR and Corvis ST (OCULUS; Wetzlar, Germany) 52 
parameters were analyzed and combined using different artificial intelligence methods 53 
(AI). The accuracies for detecting ectasia of BAD-D (Belin/Ambrósio Deviation) and CBI 54 
(Corvis Biomechanical Index) were compared to TBI, considering the areas under 55 
receiver operating characteristic curves (AUROC). Results: The random forest method 56 
with leave-one-out cross-validation (RF/LOOCV) provided the best AI model. The 57 
AUROC for detecting ectasia (groups II, III and IV) of TBI was 0.996, being statistically 58 
higher (DeLong, p<0.001) than BAD-D (0.956) and CBI (0.936). TBI cutoff value of 0.79 59 
provided 100% sensitivity for detecting clinical ectasia (groups II and III) with 100% 60 
specificity. Considering group IV, AUROC for TBI, BAD-D and CBI were 0.985, 0.839 61 
and 0.822 (DeLong, p<0.001). An optimized TBI cutoff value of 0.29 provided 90.4% 62 
sensitivity in group IV, with 96% specificity. Conclusion: TBI generated by RF/LOOCV 63 
provides accuracy for detecting ectasia, exceeding other techniques. TBI is sensitive for 64 
detecting sub-clinical (fruste) ectasia among eyes with normal topography in very 65 
asymmetric patients. TBI may also confirm unilateral disease, potentially epitomizing the 66 
inherent ectasia susceptibility of the cornea. 67 
68 
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INTRODUCTION 69 
The detection of mild or sub-clinical forms of ectatic corneal diseases (ECD) has 70 
gained momentous relevance because these cases are at very high risk for developing 71 
iatrogenic progressive ectasia (keratectasia) after corneal Laser Vision Correction (LVC) 72 
procedures.1,2 Ectasia progression after LVC occurs due to the biomechanical 73 
decompensation of corneal stroma, which is related to two different factors: the 74 
preoperative predisposition or biomechanical status of the cornea, and the structural 75 
impact from the surgical procedure. The impact from the LVC procedure may be 76 
evaluated using different parameters including the residual stromal bed (RSB) and the 77 
percent of tissue altered (PTA).3-6 In fact, the current concept is that when screening for 78 
ectasia risk among candidates for LVC, the surgeon should consider the inherent 79 
ectasia susceptibility of the cornea, which goes beyond (not over) the detection of mild 80 
cases with ECD.2 Besides elective Refractive Surgery, augmenting sensitivity for 81 
identifying mild forms of ectasia at early clinical stage and monitoring disease 82 
progression have become of utmost importance because of the definitive paradigm shift 83 
in the management of ECD, which is related to the introduction of novel therapeutic 84 
approaches such as corneal crosslinking (CXL) techniques and intrastromal corneal ring 85 
segments (ICRS) implantation.7,8 86 
The last three decades witnessed a factual revolution in corneal imaging, which 87 
includes the development of high resolution technologies capable of detailed 88 
characterizations of different aspects of corneal shape and anatomy, and the 89 
introduction of scientifically validated methods for representing and interpreting the 90 
generated data for improving the clinical decision process.9 Placido-disk based corneal 91 
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topography characterizes the anterior or front corneal surface in detail, which enables 92 
the detection of abnormal patterns of corneal shape that accompany mild forms of 93 
keratoconus in cases in which routine examination shows no abnormal findings.10 Such 94 
augmentation of sensitivity to detect ectasia among eyes with normal slit-lamp 95 
biomicroscopy and normal distance corrected visual acuity (DCVA) has positioned 96 
corneal topography as a mandatory exam for screening ectasia risk prior to LVC.1,2,10 97 
However, there are still cases that undergo ectasia progression after LVC procedures, 98 
even for low to mild corrections, despite relatively normal topography findings prior to 99 
LASIK,11-13 surface ablation,14 or SmILE (Small-Incision Lenticule Extraction).15 100 
Front surface corneal analysis (topometric or topography) evolved into the three-101 
dimension (3D) tomographic characterization, which typifies elevation of the front and 102 
back surfaces along with thickness mapping.16 Eyes with normal topometric findings 103 
from patients with clinical ectasia detected in the fellow eye have been commonly 104 
studied to demonstrate the improved ability of corneal tomography to detect ECD.17-19 In 105 
addition, the ability of tomographic data to augment the ability to detect ectasia risk or 106 
susceptibility in retrospective analysis of cases that developed keratectasia after 107 
LASIK.12,20,21 Further advances on corneal imaging allowed for segmental or layered 108 
tomographic (3D) characterization with epithelial,22,23 and Bowman’s layer thickness 109 
mapping.24 110 
Nevertheless, beyond shape analysis, clinical biomechanical assessment has 111 
been considered as an ultimate tool for enhancing the overall accuracy for identifying 112 
mild forms of ECD, along with the characterization of the inherent susceptibility of the 113 
cornea for ectasia progression.12,21 In fact, there is a consensus that the 114 
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pathophysiology of corneal ectasia is related to altered biomechanical properties.8 In 115 
addition, the current concept as proposed by Roberts and Dupps25 is that a focal 116 
abnormality in corneal biomechanical properties precipitates a cycle of decompensation, 117 
leading to secondary localized thinning and steepening (bulging), which generates 118 
optical aberrations.25 The Reichert Ocular Response Analyzer (ORA), a non-contact 119 
tonometer (NCT) that monitors corneal deformation through an infrared apical reflex, 120 
was introduced as the first clinical tool for in vivo biomechanical assessment.26 Even 121 
though ORA first generation pressure-dependent parameters – corneal hysteresis (CH) 122 
and corneal resistance factor (CRF) provided relatively low sensitivity and specificity for 123 
discriminating keratoconic from normal corneas,27 parameters derived from the corneal 124 
deformation signal were characterized, providing higher accuracy.28 Interestingly, such 125 
data were found useful to improve diagnostic accuracy for mild forms of ECD when 126 
combined with tomography data.21,29 127 
The Corvis ST (OCULUS Optikgeräte GmbH; Wetzlar, Germany) is also an NCT, 128 
but utilizes an ultra-high speed (UHS) Scheimpflug camera to monitor the deformation 129 
of the cornea in greater detail, with a collimated air pulse and fixed pressure profile.30 130 
While the first set of parameters derived from the Corvis ST measurement were found 131 
to have a relatively poor discriminant ability to detect ectatic diseases,31-33 novel 132 
parameters such as the inverse concave radius of curvature during the concave phase 133 
of the deformation response, the deformation amplitude ratio between the apex and at 134 
2mm from the apex (DA Ratio 2mm) and the stiffness parameter at first applanation 135 
(SPA1) were found to improve detection of ECD.34,35 As described by Vinciguerra and 136 
coworkers,36 the Corvis Biomechanical Index (CBI) was developed using linear 137 
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regression analysis (LRA) for combining parameters from the deformation corneal 138 
response (DCR) and from the horizontal thickness profile,37 leading to high accuracy to 139 
detect clinical keratoconus.36 Besides detection of ECD, the characterization of the 140 
deformation response has also provided an equation for intraocular pressure (IOP) 141 
correction, reducing reliance of IOP measurements on both corneal thickness and 142 
age.38 The purpose of the current study was to develop a combined parameter based 143 
on Scheimpflug imaging to advance the ability to detect clinical and sub-clinical ectasia, 144 
using corneal tomography data from the Pentacam (OCULUS Optikgeräte GmbH; 145 
Wetzlar, Germany)18 and biomechanical assessment from the Corvis ST. 146 
147 
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Methods 148 
Eight hundred and fifty eyes from 778 patients were included in this multicenter 149 
retrospective study. The patients were enrolled from two clinics located in two different 150 
continents: Instituto de Olhos Renato Ambrósio in Rio de Janeiro (Brazil), and the 151 
Vincieye Clinic in Milan (Italy). Institutional review board (IRB) from Humanitas Clinical 152 
and Research Center (Milan, Italy) ruled that approval was not required for the 153 
retrospective chart review study. The ethics committee of the Federal University of São 154 
Paulo approved this retrospective research study, which was conducted in accordance 155 
with the standards set in the 1964 Declaration of Helsinki, and revised in 2000. The 156 
eyes were divided into four groups. Group I (N) included one eye randomly selected 157 
from 480 patients with normal corneas. Group II (KC) was comprised of one eye 158 
randomly selected from 204 keratoconus patients. One eye was randomly included per 159 
patient in order to avoid selection bias related to the use of both eyes from the same 160 
subject.39 Seventy-two non-operated eyes with clinical ectasia from 94 patients with 161 
very or highly asymmetric ectasia (VAE) were included in Group III (E-VAE), whose 162 
fellow eyes presented with normal topography (Group IV – NT-VAE). Twenty-two 163 
(22/94) very asymmetric ectasia cases had one or more surgical procedures such as 164 
CXL and ICRS implantation in the ectatic eye prior to the study, and were not included 165 
in Group III because these cases did not have a Corvis ST measurement 166 
preoperatively. 167 
All patients had a comprehensive ophthalmic examination, including the Corvis 168 
ST and Pentacam HR (OCULUS Optikgeräte GmbH; Wetzlar, Germany) exams with 169 
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acceptable quality for proper analysis. Soft contact lens wear was discontinued for at 170 
least three days prior to the exam and rigid or hybrid contact lenses were discontinued 171 
for a minimal period of three weeks. The inclusion criteria for being a normal case 172 
(Group I) was to have normal corneas on the general eye exam in both eyes, including 173 
normal slit-lamp biomicroscopy, DCVA of 20/20 or better, overall subjective normal 174 
topography and tomography exams with no previous surgery and no use of topical 175 
medications different than artificial tears in both eyes. Keratoconic eyes included in this 176 
study were diagnosed with clinical ectasia in both eyes without any previous ocular 177 
procedures, such as CXL or ICRS implantation.40,41 The criteria for clinical diagnosis of 178 
ectasia included topographic characteristics, such as skewed asymmetric bow-tie, 179 
inferior steepening and at least one slit lamp finding (Munson’s sign, Vogt’s striae, 180 
Fleischer’s ring, apical thinning, Rizutti’s sign).41 Patients were considered as very 181 
asymmetric if the diagnosis of ectasia was confirmed in one eye based on the 182 
previously described criteria and the fellow had a normal front surface curvature 183 
(topometric) map. Objective criteria for considering normal topography was rigorously 184 
applied for defining the cases of Group IV, including KISA% lower than 60 and a 185 
paracentral inferior–superior (I-S value) asymmetry value at 6mm (3mm radii) less than 186 
1.45.42 These criteria avoid problems related to the subjectivity and inter and intra-187 
examiner variability of the classifications of topographic maps.43 All cases from each 188 
clinic had the tomographic data blindly re-evaluated by an expert on Anterior Segment 189 
from the other center (R. Ambrósio and P. Vinciguerra) for confirming inclusion criteria. 190 
All measurements from the Corvis ST and Pentacam HR were taken by an 191 
experienced technician. Proper exam quality was assured by a manual, frame-by-frame 192 
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analysis of each exam, made by an independent masked examiner to ensure quality of 193 
each acquisition, including good edge detection over the whole deformation response or 194 
rotating Scheimpflug images, with the exclusion of severe alignment errors (x-direction), 195 
and blinking errors. Data from Pentacam HR and Corvis ST were exported to a custom 196 
spreadsheet using special research software. 197 
 198 
Statistical Analysis 199 
Statistical analyses were performed by different software packages: MedCalc 200 
Statistical Software version 16.8.4 (MedCalc, Ostend, Belgium 201 
https://www.medcalc.org), SPSS version 23 (IBM Corp. in Armonk, NY, USA), the R 202 
Core Team version 3.3.1.2016 (R Foundation for Statistical Computing, Vienna, Austria. 203 
URL https://www.R-project.org/), and a custom-written MATLAB program (R14, The 204 
MathWorks, Natick, MA, USA). 205 
The data were analyzed and combined using different artificial intelligence 206 
methods (AI) including logistic regression analysis (LRA) with forward stepwise 207 
inclusion, support vector machine (SVM) and random forest (RF).39,44 These methods 208 
were employed to optimize the ability to distinguish normal corneas (group I) from 209 
ectatic cases (groups II, III and IV) by the combination of parameters from corneal 210 
deformation response (CDR) and tomography, including Corvis Biomechanical Index 211 
(CBI),36 and BAD-D (Belin/Ambrósio Deviation).12,18,21,34,45-48 Considering the combined 212 
parameters were programed to have their output values as a continuous number 213 
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ranging from zero to one, an LRA function was created only using the BAD-D as the 214 
input parameter to calculate BAD-DI in order to facilitate comparisons. The leave-one-215 
out cross-validation (LOOCV) technique was chosen for validation. In this method, a 216 
new model is built as many times as the number of cases included in the study. Each 217 
different model is built for all cases excluding one subject in which the model is tested. 218 
The results of the non-included cases in each of the 850 built models provide the output 219 
values of the LOOCV. Thereby, the validation model refers to the different models there 220 
were built with the leave-one-out strategy. Considering the number of false positive and 221 
false negative cases, the model would be validated or not. Once the model is properly 222 
validated for its generalized performance, a definitive algorithm would be built for all 223 
cases, which is expected to provide a more optimistic performance, but possibly with 224 
some degree of overfitting. However, it is expected that the results from the LOOCV 225 
provide a more realistic estimation of the performance when the model is applied in a 226 
novel population.  227 
The Kolmogorov-Smirnov goodness-of-fit test and D'Agostino-Pearson test were 228 
applied for checking normal distributions. Spearman rank correlation test was used to 229 
measure the degree of association between age and TBI. ANOVA was used to test 230 
differences for age among the groups. Considering all indices in the keratoconus group 231 
were non-normally distributed, the analyzed parameters were compared among the 232 
groups using the non-parametric Kurskal-Wallis test, followed by the post hoc Dunn’s 233 
test to compare each pair of groups. The discriminative ability of each parameter was 234 
assessed by Receiver operating characteristic (ROC) curves. For each parameter 235 
tested, the area under the ROC curve (AUROC) was calculated and the best cutoff 236 
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value that yielded the highest accuracy is determined along with the sensitivity and 237 
specificity. Pairwise comparisons of the AUROC were accomplished with nonparametric 238 
approach as described by DeLong and coworkers for comparing the performance of 239 
diagnostic tests.49 Furthermore, separation curves that display accuracy as a function of 240 
shifting the cut off value were plotted as described by Bühren.50 This method allows for 241 
comparisons among the different metrics by using normalized cut points by a Z 242 
transformation with the optimum cutoff set to zero. The area under the separation curve 243 
(AUSEP) was calculated between the x limits of -2 and 2 standard deviations and y 244 
limits of 50 and 100% accuracy. Thus, higher AUSEP values indicate a high 245 
discriminative ability with a high tolerance to shifts of the critical cutoff value.50  For ROC 246 
analysis a custom-written MATLAB program (R14, The MathWorks, Natick, Mass.) was 247 
used to confirm results obtained by MedCalc. 248 
  249 
 250 
 251 
252 
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Results 253 
A total of three hundred and sixty-four patients (227 healthy, 111 keratoconus 254 
and 26 cases with very asymmetric ectasia [VAE]) were enrolled from the Rio de 255 
Janeiro Corneal Tomography and Biomechanics Study Group at Instituto de Olhos 256 
Renato Ambrósio in Rio de Janeiro, Brazil. Four hundred and fourteen patients were 257 
enrolled from the Vincieye Clinic in Milan, Italy (253 healthy, 93 keratoconus and 68 258 
cases with VAE). Table 1 summarizes the demographic characteristics of the groups. 259 
Females accounted for 57.5% of normal patients, while there were 64.43% of males 260 
among ectasia patients. There were no statistically significant differences for age 261 
among the groups (ANOVA, p=0.273). However, there was a broader range in the 262 
normal group.  263 
Table 2 summarizes the descriptive statistics of the most important parameters 264 
among the groups. Central and minimal corneal thickness values, and maximal (KMax) 265 
keratometric values were normally distributed among normal eyes (p>0.5). Central 266 
(apex) thickness averaged 558µm with 30.1µm of standard deviation, ranging from 470 267 
to 674 µm. Mean thinnest pachymetry was 552µm with 30µm of standard deviation, 268 
ranging from 467 to 646µm. The average difference between central and thinnest point 269 
values was 5.8µm with 4µm of standard deviation, ranging from 0 to 24µm, with 10.4% 270 
of cases having over 10µm difference and 3.1% having over 15µm difference. Mean 271 
maximal keratometry (Kmax) was 44.38D with 1.54D of standard deviation, ranging 272 
from 40.2 to 48.5D. Eighteen eyes (3.75%) in the normal group had a positive 273 
topometric keratoconus classification (TKC).51 Six cases (1.25%) had an I-S value 274 
higher than 1.45 and 1 case (0.21%) had KISA% higher than 60. Mean BAD-D was 275 
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0.745 with 0.56 standard deviation, ranging from -1.13 to 2.35. Twenty eyes from group 276 
I (4.6%) had BAD-D values higher than 1.6 and 82 eyes (17.1%) had BAD-D values 277 
higher than 1.26 among normal eyes. CBI36 was higher than 0.5 in 2.5% of normal 278 
cases (false positives). 279 
All frank ectasia cases (groups II and III) had abnormalities detected by corneal 280 
topography that fulfilled criteria for diagnosis.41,42 However, forty-eight cases (17.4%) 281 
had Kmax lower than 47.5D and 23 cases (8.7%) had Kmax lower than 46D. The 282 
Oculus topometric classification for keratoconus (TKC)51 distribution was negative for 13 283 
cases (4.7%). Eighty-nine cases (32.2%) were classified as grade 1, 78 (28.3%) as 284 
grade 2, 67 (24.3%) as grade 3 and 29 (10.5%) cases were classified as grade 4 285 
ectasia. Four frank ectatic cases (1.4%) had BAD-D lower than 1.6, 14 cases (5.1%) 286 
had I-S value lower than 1.45D and 40 cases (14.5%) had KISA% lower than 60. CBI36 287 
was higher than 0.5 in 94.2% of frank ectatic eyes. 288 
All eyes included in group IV were objectively determined to have normal 289 
topography (NT-VAE), having I-S value lower than 1.45D, KISA% lower than 60 and no 290 
positive TKC value.42 Figure 1 displays the front surface axial or sagittal curvature 291 
(topometric) maps using Smolek-Klyce absolute 1.5D scale from the 94 NT-VAE cases. 292 
BAD-D was higher than 1.6 in 40 cases (42.6%) and higher than 1.26 in 64 cases 293 
(68.1%). Thirty-five (37.2%) cases in group IV had CBI higher than 0.5 and 42 cases 294 
(44.7%) had CBI higher than 0.3. 295 
Three different artificial intelligence approaches were applied for combining data 296 
from corneal deformation response (Corvis ST) and corneal tomography (Pentacam) 297 
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data using leave-one-out cross-validation (LOOCV). Indices were determined from the 298 
logistic regression analysis (LRAI) with forward stepwise inclusion, support vector 299 
machine (SVMI) and random forest (RF). The most accurate method was the random 300 
forest which is referred to as the TBI. A linear regression formula was applied for 301 
normalizing BAD-D into an index, with outputs ranging from zero to one (BAD-DI). The 302 
BAD-DI formula included a constant and a coefficient for BAD-D (y = a + b*x): 2.85958 303 
(constant) + (-4.84877 * BAD-D), so that BAD-D and BAD-DI have a perfect correlation. 304 
However, this approach facilitates comparison with other parameters as seen in Figure 305 
2, which display the dot-plot graphs for the BAD-D, BAD-DI, CBI, and TBI. 306 
Table 2 includes the mean, standard deviation, median and range (minimum – 307 
maximum) for the main parameters, including BAD-D, BAD-DI, CBI, LRA, SVMI and 308 
TBI. Results of Kruskal–Wallis one-way analysis of variance demonstrated differences 309 
among the studied groups for all studied parameters (p<0.000001), which was 310 
confirmed by Jonckheere-Terpstra trend test (p<0.00001). Post-hoc Dunn´s test results 311 
were similar for all parameters, confirming differences among all paired groups 312 
(p<0.001), with the exception of the comparison between keratoconus and ectatic eyes 313 
from the very asymmetric cases (group II x group III [KC x VAE-E]).  314 
Table 3 summarizes the results of receiver-operating characteristic (ROC) curve 315 
analysis and the area under the separation curve (AUSEP) calculated between the 316 
limits of -2 and +2 standard deviations. The analysis was performed for testing the 317 
discriminating abilities to separate normal cases and all diseased cases (Table 3A), 318 
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normal cases from the cases with frank ectasia (table 3B) and normal cases with the 319 
supposed subclinical cases (table 3C). These data correlate to Figure 3 (A-C).  320 
The TBI results presented refer to the outputs of the random forest method with 321 
leave-one-out cross-validation (RF/LOOCV) strategy, which provided the highest 322 
accuracy compared to LRA and SVM. The AUROC of the TBI for detecting ectasia 323 
(groups II, III and IV) was 0.996. The cut off value of 0.48 correctly classified 97.5% of 324 
the cases, having 98.8% specificity with 96.2% sensitivity. TBI had 100% sensitivity to 325 
detect frank ectasia cases (AUROC=1.0; groups II and III) with no false positives among 326 
the normal cases with optimal cut off values ranging from 0.75 to 0.81. Considering the 327 
ability to detect the eyes with normal topography from patients with clinical ectasia in the 328 
fellow eye, optimization of cut off value to 0.29 provided 90.4% sensitivity with 4% false 329 
positives (96% specificity; AUROC=0.985). TBI had a statistically higher AUROC 330 
(DeLong, p<0.001) than all other parameters for every analysis performed, except for 331 
the comparisons with BAD-D for detecting clinical ectasia cases (groups II and III), in 332 
which TBI had AUROC of 1.0 and BAD-D (and BAD-DI) had 0.997 (DeLong; p=0.1198). 333 
However, the AUSEP for BAD-D and BAD-DI were respectively 64 and 95, while TBI 334 
was 112. Such difference in AUSEP potentially confirms the higher discriminating ability 335 
of TBI than BAD-D to distinguish normal and clinical ectatic cases despite the non-336 
significant differences found among the AUROC (Table 3). TBI had a significant 337 
negative correlation with age (p<0,0001; Spearman's coefficient of rank correlation [rho] 338 
= -0.18). 339 
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The ‘final’ random forest algorithm that is programmed and included in the 340 
commercial Oculus software is based on an optimized algorithm that included all 850 341 
cases in the training set. This output provided an effectively perfect accuracy, reaching 342 
an AUROC of 1.0 for all subgroup comparisons in the current study. Considering the 343 
highest value for normal cases was 0.34 and the lowest values for frank ectatic cases 344 
(groups II and III) and for the cases in group IV were respectively 0.91 and 0.37, the cut 345 
off value of 0.35 correctly classified 100% of the cases. Interestingly, the correlation of 346 
the output of the TBI with LOOCV and the final model was highly significant (p<0.0001; 347 
Spearman's coefficient of rank correlation [rho] = 0.887).348 
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Discussion 349 
In this study, we introduce the TBI (Tomographic/Biomechanical Index) as a 350 
novel parameter based on a robust and innovative combination of data derived from 351 
Scheimpflug based corneal tomographic and biomechanical analysis. The TBI is 352 
derived from Pentacam HR and Corvis ST exams, resulting in higher accuracy for 353 
detecting ECD than all previous analyzed parameters. This was confirmed by analyzing 354 
the AUROC and AUSEP curves (Figures 2 and 3). While, it is important to include 355 
cases with mild or sub-clinical forms of ECD to facilitate appreciation of the clinical 356 
benefit for the novel parameter, the AUROC of TBI was statistically higher than all other 357 
analyzed parameters including CBI, when considering the detection of cases with 358 
clinical ectasia (groups II and III). As demonstrated by Vinciguerra and coworkers,36 CBI 359 
was accurate for detecting clinical ectasia cases, with 16 false negative cases (5.7%) 360 
and 97.5% specificity, and AUROC of 0.977 which was statistically lower than TBI. In 361 
addition, the analysis of the separation curves (AUSEP) potentially reveals the benefits 362 
of TBI over metrics that are indeed highly accurate. For example, the BAD-D12,18,21,34,45-363 
48 had 98.2% sensitivity to detect clinical ectasia with less than 1% false positives 364 
(99.2% specificity) among normal eyes in the current study. The AUROC of BAD-D (and 365 
BAD-DI) was 0.997 which is not significantly lower than the one for TBI (AUROC=1.0) 366 
accordingly to DeLong’s test to compare AUROC.49 However, the analysis of the 367 
separation curves as described by Bühren50 discloses a more dichotomous response 368 
characteristic of the TBI (Figure 2D), which is more tolerant to shifts on the cut off 369 
criterion compared to BAD-D and BAD-DI (Figure 2A).  370 
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The study included a large cohort of patients with normal corneas and with 371 
different levels of ectatic corneal disease (ECD). In order to avoid selection bias related 372 
to the use of both eyes from the same subject, we included one eye randomly selected 373 
per patient in groups I and II.39 Seventy two patients had one eye in group III and the 374 
other eye in group IV. While these patients had both eyes included, these cases were 375 
by definition highly asymmetric, which avoids the problems related to enantiomorphism 376 
or similarities between right and left eyes. Considering the limitations of subjective 377 
interpretation of corneal topography maps,43 we were restricted to applying front surface 378 
curvature indices as described by Rabinowitz42 for objectively defining the inclusion 379 
criteria of group IV.  Interestingly, even after twenty-three cases from the preliminary set 380 
of group IV were reclassified into group II due to the above criteria, some cases from 381 
group IV would still be found with suspicious curvature maps (Figure 1).  382 
The current study included 94 eyes that reached objective criteria for normal 383 
corneal topography from patients with clinical ectasia in the fellow eye. This constitutes 384 
one of the largest cohort studies including such a special group of cases.17-19,52 TBI was 385 
sensitive to detect abnormalities among 90.4% of cases in Group IV with less than 5% 386 
false positives. However, while these cases have been referred to as forme fruste 387 
keratoconus by Klyce,53 it is important to consider that some of these cases may be true 388 
unilateral ectasia cases.54 Remarkably, there is a consensus that true unilateral 389 
keratoconus does not exist, but also that secondary, induced ectasia caused by a pure 390 
mechanical process, such as eye rubbing, may occur unilaterally.8 These ideas are in 391 
agreement with the two-hit hypothesis, which put forward the concept of ectasia to 392 
result from an underlying genetic predisposition along with external environmental 393 
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factors, including eye rubbing and atopy.7 Our hypothesis is that TBI may reflect the 394 
inherent susceptibility of the cornea to ectasia progression.  395 
A possible study for assessing ectasia susceptibility involves the analysis of the 396 
preoperative state of cases that developed ectasia after LVC along with the surgical 397 
parameters which represent the impact from surgery on the cornea.20 Another possible 398 
approach is to integrate finite element simulations with the corneal structural and shape 399 
analysis. In addition, adding longitudinal analysis for a retrospective evaluation of 400 
patients that progressed to clinical ectasia would further improve criteria to define such 401 
a group.21 Even though we included a relatively large number of cases with mild ECD, 402 
50% of the cases from groups II and III had Kmax lower than 52D and 65% had TKC 403 
grade 2 or lower.    404 
A limitation of the current cohort may be the criteria for inclusion in Group I. Even 405 
though this is expected to be relatively rare, it is possible that some eyes with a normal 406 
clinical exam, including corneal topography and tomography, have mild or susceptible 407 
forms of ectasia such as in cases that progressed to keratectasia after different LVC 408 
procedures.11-15 The preoperative state of stable cases with long term follow up after 409 
LVC would provide a more robust population for the normal control group.17,20,34 410 
The random forest method provided the most efficient strategy for developing 411 
TBI. In this advanced compound artificial intelligence based model, analysis starts like 412 
an ordinary decision tree. This includes successive nodes defined by independent 413 
variables with objective decisions based on cut off values. As in a classic decision tree, 414 
the analyzed case is successively split into two mutual subgroups (branches) that 415 
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subdivide until a final decision of class assignment (leaves). The random forest takes 416 
this approach to the next level by combining numerous trees with the concept of an 417 
ensemble or cooperative effort. The algorithm grows the trees by sampling the data into 418 
random subgroups. Some input variables are also randomly selected to test their 419 
capability of splitting the data at each node. The predictor variable that provides the best 420 
split, according to an objective function is applied on each node. Each tree gets a "vote" 421 
in classifying. The final classification is based on the votes of all trees for providing a 422 
combined value that typically varies from zero to one.44 The increase in complexity 423 
enhances the power of discrimination and reduces the chances of overfitting. 424 
Nevertheless, as for any machine learning method, it is fundamental to include a cross-425 
validation method to infer or presume external validity of the model. In the current study, 426 
the leave-one-out cross-validation (LOOCV) was chosen. The LOOCV method 427 
increases computational time and complexity, but also significantly increases the 428 
reliability or robustness of the model in classifying new data. Interestingly, TBI accuracy, 429 
as presented in Figures 2D and 3, refers to the output values from the LOOCV strategy. 430 
This is indeed a slightly pessimistic performance compared to the virtually perfect 431 
accuracy that would have been found with the ‘final’ TBI model that is programmed in 432 
the commercial Oculus software. Nevertheless, the result from the LOOCV outputs is 433 
essentially a more conservative and also a more truthful representation of the 434 
generalized performance for the TBI. This is a fundamental consideration that will be 435 
addressed in future studies for external validation of TBI, which are already underway.   436 
TBI is a combined parameter based on Scheimpflug-based corneal tomography 437 
and biomechanical assessments. It provides exceeding accuracy for detecting ectasia 438 
Ambrósio et al: Tomographic/Biomechanical Index (TBI) for Ectasia detection Page 22 
 
 
comparing to other parameters, with high sensitivity for detecting sub-clinical (fruste) 439 
ectasia among eyes with normal topography in very asymmetric patients. TBI may also 440 
be considered as an objective index for representing the inherent susceptibility of the 441 
cornea to undergo ectasia progression, which is highly relevant when screening 442 
refractive surgery candidates. 443 
  444 
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Figure legends 583 
Figure 1: Front surface axial or sagittal curvature (topometric) maps using Smolek-584 
Klyce absolute 1.5D scale from the 94 cases included in Group IV (VAE-NT). 585 
Figure 2: box and dot plots showing the distribution of metric values across the groups. 586 
A, BADD  B, BADDI  C, CBI  D, LRI  E, SVMI  F, TBI. The box spans the 1st and 3rd 587 
quartile. the whiskers indicate the 1.5-fold interquartile range. Colored markers 588 
representing each value and their mean are superimposed. 589 
Figure 3: receiver-operating characteristic and separation curves for the different 590 
metrics. A, group I (normals) vs. groups II (keratoconus), III (very asymmetric ectasia) 591 
and IV (topographically normal fellow eyes of very asymmetric ectasia eyes)  B, group I 592 
vs. groups II and III  C, group I vs. groups IV. 593 
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Tables 
Table 1. Demographic Characteristics of the Groups 
 
RIO Milano 
 
n Male Female 
Ave Age 
(min - max) n Male Female 
Ave Age 
(min - max) 
group I 
(normals) 227 96 131 
37.71 
(7 – 90) 253 108 145 
43.20 
(7 – 88) 
group II 
(KC eyes) 111 72 39 
32.90 
(12 – 64) 93 66 27 
38.10 
(16 – 72) 
group III 
(E-VAE eyes) 19 10 9 
32.89 
(14 – 74) 53 30 23 
36.96 
(13 – 83) 
group IV 
(NT-VAE eyes) 26 15 11 
35.02 
(14 – 74) 68 39 29 
37.66 
(13 – 83) 
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Table 2: Descriptive statististics. Mean ± standard deviation; median (minimum – maximum) 
 group I (normals) group II  (KC eyes) group III (E-VAE eyes) group IV (NT-VAE) 
I-S  
Value 
0.16 ±0.55 5.79 ±4.32 5.17 ±3.63 0.53 ±0.51 
0.16 (-1.46 - 1.91) 4.80 (-2.60 - 33.69) 4.34 (-2.07 - 16.07) 0.61 (-0.76 - 1.42) 
KISA 10.73 ±13.95 2699.29 ±12870.32 1579.36 ±4666.63 13.81 ±14.88 
5.24 (0.33 - 82.62) 369.72 (2.30 - 173021) 285.03 (2.79 - 35153) 7.51 (0.33 - 59.20) 
Pachy Min 552.56 ±29.99 466.86 ±47.84 480.11 ±42.14 517.66 ±30.95 
553 (467 - 646) 468.50 (173 - 596) 479.50 (351 - 581) 521 (449 - 599) 
Pachy Apex 558.45 ±30.10 488.60 ±123.24 493.85 ±43.37 525.98 ±29.68 
559 (470 - 647) 485 (209 - 213) 492.50 (356 - 583) 529 (451 - 606) 
ART Max 469.84 ±76.56 177.63 ±76.08 197.58 ±88.84 369.89 ±77.23 
463 (247 - 744) 166.50 (0.00 - 460) 174 (66.00 - 442) 365 (190 - 546) 
ART Avg 601.90 ±93.58 261.34 ±104.37 292.61 ±110.97 491.43 ±78.47 
591.50 (359 - 985) 259.50 (0.00 - 653) 270.50 (101 - 609) 487.5 (298 - 667) 
EleF 
BFS8mm 
Thinnest 
1.90 ±1.63 19.60 ±19.33 19.00 ±10.46 2.83 ±1.74 
2.00 (-4.00 - 8.00) 16.50 (-50.00 - 72.00) 16.50 (0.00 - 49.00) 3.00 (-2.00 - 9.00) 
EleB 
BFS 
8mmThinnest 
6.04 ±4.40 56.04 ±125.78 44.47 ±20.86 9.39 ±5.21 
6.00 (-5.00 - 19.00) 42.00 (2.00 - 1805.00) 43.00 (12.00 - 95.00) 9.00 (1.00 - 27.00) 
SP_A1 106.30 ±17.65 66.84 ±24.11 67.25 ±24.90 85.19 ±26.04 
104.81 (60.69 - 165.00) 66.72 (2.91 - 150.11) 65.66 (32.33 - 116.74) 89.29 (35.22 - 142.45) 
DARatioMax 
2mm 
4.30 ±0.50 5.86 ±1.56 5.53 ±1.21 4.83 ±0.64 
4.30 (3.19 – 5.60) 5.58 (3.20 – 15.36) 5.33 (3.55 – 8.77) 4.71 (3.68 – 6.52) 
MaxInverse 
Radius 
Gauss5Fmm1 
0.16 ±0.02 0.21 ±0.05 0.20 ±0.04 0.17 ±0.02 
0.15 (0.08 – 0.24) 0.20 (0.12 – 0.51) 0.19 (0.12 – 0.31) 0.17 (0.12 – 0.28) 
BAD-D 0.75 ±0.56 7.97 ±4.66 6.97 ±3.64 1.61 ±0.68 
0.8 (1.13 - 2.35) 6.93 (0.76 - 25.94) 6.37 (1.82 - 18.79) 1.53 (0.18 - 3.22) 
BAD-DI 0.12 ±0.14 0.98 ±0.11 0.99 ±0.06 0.44 ±0.31 
0 (0.070 - 0.87) 1 (0.06 – 1) 1 (0.59 – 1) 0.38 (0.01 - 0.99) 
CBI 0.06 ±0.14 0.92 ±0.22 0.91 ±0.24 0.41 ±0.4 
0 (0 - 0.88) 1 (0 – 1) 1 (0 – 1) 0.24 (0 – 1) 
LRAI 0.11 ±0.15 0.88 ±0.26 0.81 ±0.33 0.87 ±0.28 
0 (0.050 - 0.79) 1 (0.03 – 1) 1 (0.02 – 1) 1 (0.02 – 1) 
SVMI 0.1 ±0.11 0.88 ±0.28 0.81 ±0.35 0.88 ±0.3 
0.08 (0.04 - 0.95) 1 (0.07 – 1) 1 (0.05 – 1) 1 (0.04 – 1) 
TBI 0.07 ±0.1 0.97 ±0.04 0.97 ±0.04 0.76 ±0.28 
0 (0.070 - 0.75) 0.97 (0.83 – 1) 0.97 (0.87 – 1) 0.76 (0.08 – 1) 
KC: keratoconus, VAE-E: ectatic eye from patients with very asymmetric ectasia, VAE-NT: normal topography fellow eye from 
patients with very asymmetric ectasia. BAD-D: Belin/Ambrósio Deviation value; BAD-DI: Belin/Ambrósio Deviation normalized 
index; CBI: Corvis Biomechanical Index; DA Ratio 2mm: deformation amplitude ratio between the apex and at 2mm from the apex; 
I-S: paracentral inferior–superior asymmetry value at 6mm (3mm radii); KISA: keratoconus percentage index; LRAI: linear 
regression analysis index; MaxInverse Radius: inverse of maximal inverse radius at highest concavity; Pachy Apex: pachymetric 
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value at the corneal apex: Pachy Min: pachymetric value at the corneal apex; SPA1: stiffness parameter at first applanation; SVMI: 
support vector machine; TBI: tomographic & biomechanical index. 
Table 3: Results of receiver-operating characteristic (ROC) curve analysis. 
A. groups I vs. [II,III,IV]:  normal vs. ‘diseased’ (KC, E-VAE and NT-
VAE fellow eyes; Figure 2A) 
Parameter AUROC Sensitivi
ty 
Specificity correctly 
classified [%] 
cutoff specificity 
@ 100% 
sensitivity 
AUSEP 
BAD-D 0.956 0.841 0.965 90.3 1.62 14 51 
BAD-DI 0.956 0.841 0.965 90.3 0.45 14 83 
CBI 0.937 0.808 0.971 88.9 0.46 0 82 
LRAI 0.967 0.884 0.960 92.2 0.44 31 95 
SVMI 0.964 0.868 0.975 92.1 0.34 1 105 
TBI 0.996 0.962 0.988 97.5 0.48 72 110 
        
B. groups I vs. [II,III]:  normal vs. frank ectasia (KC and E-VAE eyes; 
Figure 2B) 
parameter AUROC sensitivit
y 
specificity correctly 
classified [%] 
cutoff specificity 
@ 100% 
sensitivity 
AUSEP 
BAD-D 0.997 0.982 0.992 98.7 1.97 47.3 64 
BAD-DI 0.997 0.982 0.992 98.7 0.69 47.3 95 
CBI 0.977 0.946 0.975 96.0 0.49 12.9 95 
LRAI 0.967 0.888 0.960 92.4 0.44 32 99 
SVMI 0.964 0.877 0.967 92.2 0.30 1 109 
TBI 1.000 1.000 1.000 100.0 0.79 100 112 
        
C. groups I vs. IV: normal vs. NT- VAE fellow eyes (Figure 2C) 
parameter AUROC sensitivity specificity correctly 
classified [%] 
cutoff specificity 
@ 100% 
sensitivity 
AUSEP 
BAD-D 0.838 0.809 0.717 76.3 1.08 14 49 
BAD-DI 0.838 0.809 0.717 76.3 0.14 14 47 
CBI 0.822 0.681 0.823 75.2 0.07 0 46 
LRAI 0.968 0.872 0.969 92.1 0.51 31 125 
SVMI 0.965 0.851 1.000 92.6 0.96 1 79 
TBI 0.985 0.904 0.960 93.2 0.29 71.9 99 
KC: keratoconus, E-VAE: ectatic eye from patients with very asymmetric ectasia, NT-VAE: normal 
topography fellow eye from patients with very asymmetric ectasia, AUROC area under the ROC curve, 
AUSEP: area under the separation curve 
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